Stock A052670 CHEILBIO CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Cheilbio Co., Ltd.

Equities

A052670

KR7052670007

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 19/07/2023 BST 		5-day change 1st Jan Change
2,080 KRW -9.96% Intraday chart for Cheilbio Co., Ltd. -.--% -.--%
2023 Cheilbio Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 Cheilbio Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 57,000 103,950 113,550 93,941 33,630 56,184
Enterprise Value (EV) 1 43,505 86,186 88,336 68,196 11,543 36,359
P/E ratio 49.9 x 45.5 x 107 x -128 x -20 x -38.9 x
Yield - - - - - -
Capitalization / Revenue 2.05 x 4.52 x 5.98 x 5.55 x 2.19 x 4.64 x
EV / Revenue 1.56 x 3.75 x 4.65 x 4.03 x 0.75 x 3 x
EV / EBITDA 24.5 x 94.4 x -709 x -48.7 x -9.44 x -17.7 x
EV / FCF 43.1 x 598 x 31.1 x -32.2 x 6.18 x -8.86 x
FCF Yield 2.32% 0.17% 3.21% -3.11% 16.2% -11.3%
Price to Book 1.72 x 2.94 x 2.8 x 2.44 x 1.02 x 1.81 x
Nbr of stocks (in thousands) 30,000 30,000 30,000 29,129 27,012 27,012
Reference price 2 1,900 3,465 3,785 3,225 1,245 2,080
Announcement Date 01/03/19 29/02/20 01/03/21 01/03/22 01/03/23 29/02/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 27,810 22,986 18,999 16,912 15,349 12,111
EBITDA 1 1,773 913.4 -124.6 -1,401 -1,223 -2,054
EBIT 1 1,403 520.1 -487.6 -1,726 -1,485 -2,235
Operating Margin 5.05% 2.26% -2.57% -10.21% -9.68% -18.46%
Earnings before Tax (EBT) 1 1,323 2,496 1,230 138.2 -1,756 -1,464
Net income 1 1,040 2,043 993.8 -712.4 -1,708 -1,446
Net margin 3.74% 8.89% 5.23% -4.21% -11.13% -11.94%
EPS 2 38.05 76.23 35.28 -25.21 -62.20 -53.52
Free Cash Flow 1 1,009 144.1 2,837 -2,119 1,868 -4,104
FCF margin 3.63% 0.63% 14.93% -12.53% 12.17% -33.89%
FCF Conversion (EBITDA) 56.94% 15.77% - - - -
FCF Conversion (Net income) 97.04% 7.05% 285.46% - - -
Dividend per Share - - - - - -
Announcement Date 01/03/19 29/02/20 01/03/21 01/03/22 01/03/23 29/02/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 13,495 17,764 25,214 25,745 22,087 19,826
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 1,009 144 2,837 -2,119 1,868 -4,104
ROE (net income / shareholders' equity) 3.46% 6.67% 2.85% -1.89% -4.85% -4.51%
ROA (Net income/ Total Assets) 2.69% 0.97% -0.79% -2.64% -2.53% -4.12%
Assets 1 38,676 210,482 -126,009 27,000 67,591 35,098
Book Value Per Share 2 1,108 1,180 1,352 1,321 1,223 1,150
Cash Flow per Share 2 46.00 207.0 208.0 218.0 654.0 436.0
Capex 1 180 13.9 13.9 65 11.5 214
Capex / Sales 0.65% 0.06% 0.07% 0.38% 0.08% 1.77%
Announcement Date 01/03/19 29/02/20 01/03/21 01/03/22 01/03/23 29/02/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Veterinary Drugs

1st Jan change Capi.
CHEILBIO CO., LTD. Stock Cheilbio Co., Ltd.
-.--% 41.71M
ZOETIS INC. Stock Zoetis Inc.
-11.98% 79.26B
ELANCO ANIMAL HEALTH INCORPORATED Stock Elanco Animal Health Incorporated
+13.86% 8.39B
BLUESTAR ADISSEO COMPANY Stock Bluestar Adisseo Company
+25.75% 3.74B
VIRBAC Stock Virbac
-0.70% 3.27B
VIMIAN GROUP AB Stock Vimian Group AB
+15.20% 1.69B
JINYU BIO-TECHNOLOGY CO., LTD. Stock Jinyu Bio-technology Co., Ltd.
-6.22% 1.56B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD. Stock China Animal Husbandry Industry Co., Ltd.
-23.36% 1.29B
VETOQUINOL SA Stock Vetoquinol SA
-1.37% 1.28B
WUHAN KEQIAN BIOLOGY CO.,LTD Stock Wuhan Keqian Biology Co.,Ltd
-12.76% 1.14B
Veterinary Drugs
  1. Stock Market
  2. Equities
  3. A052670 Stock
  4. Financials Cheilbio Co., Ltd.